losartan has been researched along with Diarrhea in 4 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There is currently little information available on the efficacy, safety, and individual tolerance of patients with post-diarrheal hemolytic uremic syndrome (D+ HUS) nephropathy to therapies involving diet, enalapril, or losartan." | 9.15 | Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy. ( Caletti, MG; Exeni, R; Grignoli, M; Missoni, M; Piantanida, JJ; Rasse, SM; Repetto, HA; Vezzani, C, 2011) |
| " There is currently little information available on the efficacy, safety, and individual tolerance of patients with post-diarrheal hemolytic uremic syndrome (D+ HUS) nephropathy to therapies involving diet, enalapril, or losartan." | 5.15 | Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy. ( Caletti, MG; Exeni, R; Grignoli, M; Missoni, M; Piantanida, JJ; Rasse, SM; Repetto, HA; Vezzani, C, 2011) |
| " As proteinuria persisted, losartan was added at a median dose of 1." | 3.79 | Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome. ( Balestracci, A; Caletti, MG; Missoni, M; Vezzani, C, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Gils, T | 1 |
| Robijn, RJ | 1 |
| Bouma, G | 1 |
| Neefjes-Borst, EA | 1 |
| Mulder, CJJ | 1 |
| Caletti, MG | 2 |
| Missoni, M | 2 |
| Vezzani, C | 2 |
| Grignoli, M | 1 |
| Piantanida, JJ | 1 |
| Repetto, HA | 1 |
| Exeni, R | 1 |
| Rasse, SM | 1 |
| Balestracci, A | 1 |
| Krum, H | 1 |
| Nolly, H | 1 |
| Workman, D | 1 |
| He, W | 1 |
| Roniker, B | 1 |
| Krause, S | 1 |
| Fakouhi, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC)[NCT02354170] | Phase 2 | 16 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for losartan and Diarrhea
| Article | Year |
|---|---|
Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Diarrhea; Diet Therapy; Do | 2011 |
Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiot | 2002 |
2 other studies available for losartan and Diarrhea
| Article | Year |
|---|---|
A Pitfall in Suspected (refractory) Celiac Disease: Losartan-Induced Enteropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Biopsy; Celiac Disease; Diagnosis, Differential; Diarrhea; | 2017 |
Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Pre | 2013 |